Workplace chronic disease management programs pay off
News brief.
Research Headlines
Workplace chronic disease management programs pay off
By Jeanne Sabatie, Production Editor
Results from a worksite asthma education program, conducted by Wayne Burton, MD (B&H editorial board member and corporate medical director at Bank One in Chicago) and colleagues, showed improved asthma control behaviors of participants. The data suggests that such programs should reduce absenteeism and medical care costs and improve productivity. The report is in the February issue of the Journal of Occupational and Environmental Medicine.
Jeanne Sabatie. Workplace chronic disease management programs pay off.
Business and Health
2001;4:10.
FDA Approves Amvuttra for ATTR-CM in Extended Label
March 21st 2025This expanded indication for Amvuttra makes it the first and only FDA-approved treatment for transthyretin amyloidosis with cardiomyopathy (ATTR-CM) and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
FDA Approves First-Ever Cell Therapy Treatment for Rare Progressive Eye Disease
March 20th 2025Encelto is small, semi-permeable capsule implanted in the eye that contains allogeneic retinal pigment epithelium cells genetically engineered to produce specific therapeutic proteins. It will be available in June 2025.
Read More
